Track eloralintide in Peptimes™
Eloralintide (LY3841136) is an investigational modified peptide with a fatty-acid chain attached, listed in FDA's substance registry. Eli Lilly and Company is studying it in Phase 3 trials. (Source: FDA's substance registry (GSRS).)
Is eloralintide FDA-approved?
No. Eloralintide is investigational: it's being studied in clinical trials and isn't FDA-approved for any use.
Eloralintide
Also: LY3841136, AMY-1176
- Status label in the Peptimes Library
- Phase 3 Trials
- Routes in Peptimes
- Subcutaneous
- Updated
- 1 Nov 2026
US regulatory status
FDA status
Not FDA-approved for any use. Drugs@FDA lists no application with eloralintide as an active ingredient.
Source: Drugs@FDA, checked 1 Nov 2026
Investigational
Yes.
Source: ClinicalTrials.gov, checked 1 Nov 2026
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- In humans
ENLIGHTEN-1, a double-blind, placebo-controlled Phase 3 trial in about 1,980 adults with obesity, or overweight without type 2 diabetes, measures the change in body weight. It began in February 2026 and is recruiting; no results yet.
Source: NCT07321886, checked 1 Nov 2026
How to track it in Peptimes
Add eloralintide in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Phase 3 Trials”, which describes its investigational status. It isn’t an approval.
- Logging: the amount you took and how you feel.
- Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell eloralintide or any other compound.
More sources
- NIH, ClinicalTrials.gov, ENLIGHTEN-1 (NCT07321886), checked 1 Nov 2026: a Phase 3 study of eloralintide sponsored by Eli Lilly and Company, recruiting.
- NIH, ClinicalTrials.gov, studies of eloralintide, checked 1 Nov 2026: registered studies, all sponsored by Eli Lilly and Company, including Phase 3 studies.
- FDA, Drugs@FDA, searched 1 Nov 2026: no application lists eloralintide as an active ingredient.
- FDA, Global Substance Registration System, Eloralintide, checked 1 Nov 2026: its structure and the codes LY3841136 and AMY-1176.